• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?

The New York Times – Business:

Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.

Apoorva Mandavilli
Author: Apoorva Mandavilli

This post first appeared in The New York Times – Business. Read the original article.

Written by

Apoorva Mandavilli

in

Drugs (Pharmaceuticals), Europe, Gender, Janssen Pharmaceutica, Johnson & Johnson, North America, South America, Vaccination and Immunization, Viruses
←Russian Citizen Accused of Running Cryptocurrency Exchange Used by Criminals
In Philadelphia, a Cocktail Bar With Bold Colors and Swedish Meatballs→

More posts

  • Spotify once had a reputation for underpaying music artists. It hopes to change that perception

  • How Trump and His Advisers Miscalculated Iran’s Response to War

  • Mickey Rourke evicted over $60,000 in unpaid rent after turning down $100,000 in donations

  • Georgia special election to replace Marjorie Taylor Greene headed to runoff

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube